InspireMD, Inc.

NSPR

Held by 1 specialist biotech fund

Share on X

Fund Holdings

OrbiMed Advisors

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

OrbiMed AdvisorsNEWFeb 17, 2026

Shares: 3,133,405Value: $5.6M

**Signal Note: OrbiMed Initiates $5.6M Position in InspireMD (NSPR)** OrbiMed's entry suggests conviction in InspireMD's MGuard Prime coronary stent platform, likely ahead of pending clinical or regulatory milestones; the device targets high-risk PCI patients where embolic protection remains underserved. The investment timing may reflect anticipated data readouts or reimbursement decisions that could unlock margin expansion in the $12B+ interventional cardiology market.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

APLS1 fund RNA1 fund BIOA1 fund IRON1 fund ANRO1 fund FOLD1 fund BCAX1 fund ARGX

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: